Page last updated: 2024-10-27

fenofibrate and Atrophy

fenofibrate has been researched along with Atrophy in 2 studies

Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE

Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.

Research Excerpts

ExcerptRelevanceReference
"Fenofibrate treatment prevented arthritis-induced increase in atrogin-1 and MuRF1 expression in the gastrocnemius."5.37Fenofibrate, a PPAR{alpha} agonist, decreases atrogenes and myostatin expression and improves arthritis-induced skeletal muscle atrophy. ( Castillero, E; Fernández-Galaz, C; Granado, M; López-Calderón, A; López-Menduiña, M; Martín, AI; Nieto-Bona, MP; Villanúa, MA, 2011)
"Fenofibrate treatment prevented arthritis-induced increase in atrogin-1 and MuRF1 expression in the gastrocnemius."1.37Fenofibrate, a PPAR{alpha} agonist, decreases atrogenes and myostatin expression and improves arthritis-induced skeletal muscle atrophy. ( Castillero, E; Fernández-Galaz, C; Granado, M; López-Calderón, A; López-Menduiña, M; Martín, AI; Nieto-Bona, MP; Villanúa, MA, 2011)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Ajima, H1
Kai, Y1
Fujimaki, J1
Akashi, S1
Morita, A1
Ezaki, O1
Kamei, Y1
Miura, S1
Castillero, E1
Nieto-Bona, MP1
Fernández-Galaz, C1
Martín, AI1
López-Menduiña, M1
Granado, M1
Villanúa, MA1
López-Calderón, A1

Other Studies

2 other studies available for fenofibrate and Atrophy

ArticleYear
Effects of fenofibrate and its combination with lovastatin on the expression of genes involved in skeletal muscle atrophy, including FoxO1 and its targets.
    The Journal of toxicological sciences, 2021, Volume: 46, Issue:1

    Topics: Animals; Atrophy; Drug Therapy, Combination; Fenofibrate; Forkhead Box Protein O1; Gene Expression;

2021
Fenofibrate, a PPAR{alpha} agonist, decreases atrogenes and myostatin expression and improves arthritis-induced skeletal muscle atrophy.
    American journal of physiology. Endocrinology and metabolism, 2011, Volume: 300, Issue:5

    Topics: Animals; Arthritis, Experimental; Atrophy; Body Weight; Eating; Fenofibrate; Gene Expression; Hypoli

2011